• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROCEPT BIOROBOTICS CORPORATION AQUABEAM SYSTEM; FLUID JET REMOVAL SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROCEPT BIOROBOTICS CORPORATION AQUABEAM SYSTEM; FLUID JET REMOVAL SYSTEM Back to Search Results
Catalog Number 220101
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Perforation (2001)
Event Date 05/10/2018
Event Type  Injury  
Manufacturer Narrative
A review of the log file was conducted and no anomalies were observed.The review indicated that the system functioned as designed.A review of the device history record (dhr) for the aquabeam system, lot number 18c00106, was conducted, which confirmed that there were no nonconformances generated during the manufacturing process of this system, which could relate to the reported event.The review indicated that the system met all required specifications when released for distribution.The aquabeam system's instructions for use (ifu), ifu320301, rev.D, was reviewed and capsular perforation is listed as a potential perioperative risk of the aquablation procedure.The system was not returned for investigation of this complaint.Capsular perforation is a potential risk of the aquablation procedure.Based on the review of the log file, dhr, and ifu, the event is considered not to be device related.
 
Event Description
A male patient underwent an aquablation procedure.Per standard post-aquablation procedure, during clot evacuation a prostatic capsule perforation was seen by transrectal ultrasound (trus) and later confirmed by cystoscopy (per manufacturer's instructions for use, prostate capsule perforation is a potential perioperative risk of the aquablation procedure).In response to the capsular perforation, the physician decided to leave the foley balloon urinary catheter in place for four (4) days rather than the typical one (1) to two (2) days post-aquablation procedure to allow for healing of the perforation.There were no reported adverse health consequences to the patient following removal of the catheter or as result of the capsular perforation.No malfunction of the aquabeam system was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AQUABEAM SYSTEM
Type of Device
FLUID JET REMOVAL SYSTEM
Manufacturer (Section D)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city, ca
Manufacturer (Section G)
PROCEPT BIOROBOTICS CORPORATION
900 island drive
suite 101
redwood city, ca
Manufacturer Contact
doria esquivel
900 island drive
suite 170
redwood city, ca 
2327291
MDR Report Key9775038
MDR Text Key188340343
Report Number3012977056-2020-00003
Device Sequence Number1
Product Code PZP
Combination Product (y/n)N
Reporter Country CodeLE
PMA/PMN Number
DEN170024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number220101
Device Lot Number18C00106
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/10/2018
Initial Date FDA Received03/02/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/09/2018
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-